IL1B and neoplasm: In order to test if sorafenib could act through the activation of the inflammasome in tumor-associated macrophages (TAMs), PMA-activated THP-1 cells were treated with sorafenib and MCC950, and IL-1β production was detected in the cellular media after 16 h.